Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
12:23pm, Tuesday, 02'nd Dec 2025
Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Pre-Market Stock Futures: The futures are trading higher this morning. Sellers regained the upper hand on Monday, starting the final trading month of 2025 on the downside after a blazing Thanksgiving-
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
06:44pm, Monday, 01'st Dec 2025
Three stocks that are performing well in 2025 just made notable buyback announcements. All three have achieved returns north of 20% this year, beating the 18% return of the S&P 500 Index.
Solventum Corporation $SOLV Shares Sold by Creative Planning
05:14am, Thursday, 27'th Nov 2025
Creative Planning reduced its position in shares of Solventum Corporation (NYSE: SOLV) by 5.8% during the undefined quarter, according to the company in its most recent filing with the Securities and
Solventum Corporation $SOLV Stock Position Raised by Boston Partners
03:52am, Thursday, 27'th Nov 2025
Boston Partners increased its holdings in shares of Solventum Corporation (NYSE: SOLV) by 9.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
04:05pm, Tuesday, 25'th Nov 2025
ST. PAUL, Minn. , Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec.
What Moved Markets This Week
06:50am, Saturday, 22'nd Nov 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Solventum Announces Agreement to Acquire Acera Surgical
09:00am, Thursday, 20'th Nov 2025
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million marke
Solventum Announces $1 Billion Share Repurchase Program
09:00am, Thursday, 20'th Nov 2025
ST. PAUL, Minn. , Nov. 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to
Nelson Peltz's Strategic Moves: U-Haul Holding Co Exit Impacts Portfolio by -0.56%
05:11pm, Friday, 14'th Nov 2025
Exploring Nelson Peltz (Trades, Portfolio)'s Recent 13F Filing and Investment Strategy Nelson Peltz (Trades, Portfolio) recently submitted the 13F filing for t
Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript
01:51pm, Wednesday, 12'th Nov 2025
Solventum Corporation ( SOLV ) Stifel 2025 Healthcare Conference November 12, 2025 11:20 AM EST Company Participants Wayde McMillan - Chief Financial Officer Doug Bartlett Conference Call Participants
SOLV vs. DHR: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 12'th Nov 2025
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and Danaher (DHR). But which of these two stocks offers value investors a better bang for their buck right now
Solventum (SOLV) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:01pm, Tuesday, 11'th Nov 2025
Solventum (SOLV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance
09:17am, Tuesday, 11'th Nov 2025
Solventum which has barely moved since our coverage 14 months back, delivered mixed Q3 results last week. SOLV managed to beat both topline and bottomline estimates (although the degree of beat on the
Bank of Montreal Can Reduces Stock Holdings in Solventum Corporation $SOLV
04:22am, Tuesday, 11'th Nov 2025
Bank of Montreal Can reduced its position in shares of Solventum Corporation (NYSE: SOLV) by 33.8% in the second quarter, according to the company in its most recent filing with the Securities and Exc
